HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.

AbstractOBJECTIVE:
To evaluate, whether Gonadotropin-releasing hormone-agonist (GnRH-agonist or GnRH-ag) trigger in patients undergoing the ultrashort GnRH-ag/GnRH-antagonist (GnRH-ant) protocol is as effective as in patients at high risk to develop severe ovarian hyperstimulation syndrome (OHSS), who undergo the multidose GnRH-ant protocol.
DESIGN:
Cohort study.
SETTING:
University hospital.
PATIENTS:
All consecutive women aged ≤35 years admitted to our IVF unit from January 2011 to October 2011 who reached the ovum pick-up stage.
INTERVENTIONS:
Triggering final oocytes maturation by GnRH-ag instead of hCG, in high-responder patients undergoing either the ultrashort GnRH-ag/GnRH-ant or the multidose GnRH-antagonist controlled ovarian hyperstimulation (COH) protocols.
MAIN OUTCOME MEASURES:
Ovarian stimulation characteristics, percentage of mature oocytes, fertilization and pregnancy rates.
RESULTS:
No inbetween groups differences were observed in ovarian-stimulation related variable, percentage of mature oocytes, fertilization or pregnancy rates. No case of moderate-severe OHSS was reported in the study, or the control groups.
CONCLUSIONS:
Three consecutive doses of daily GnRH-ag administration at the beginning of ultrashort flare GnRH-ag/GnRH-ant COH protocol, did not interfere with the ability of the GnRH-ag to trigger final oocytes maturation at the end of the COH cycle.
AuthorsRaoul Orvieto, Ravit Nahum, Efraim Zohav, Gad Liberty, Eyal Y Anteby, Simion Meltcer
JournalGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (Gynecol Endocrinol) Vol. 29 Issue 1 Pg. 51-3 (Jan 2013) ISSN: 1473-0766 [Electronic] England
PMID22857268 (Publication Type: Journal Article)
Chemical References
  • Gonadotropins
  • Luteolytic Agents
  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone
Topics
  • Adult
  • Cohort Studies
  • Databases, Factual
  • Female
  • Fertilization (drug effects)
  • Fertilization in Vitro (methods)
  • Gonadotropin-Releasing Hormone (agonists, antagonists & inhibitors)
  • Gonadotropins (administration & dosage)
  • Humans
  • Infertility, Female (drug therapy, epidemiology)
  • Luteolytic Agents (administration & dosage)
  • Oocytes (cytology, drug effects)
  • Ovarian Hyperstimulation Syndrome (epidemiology, prevention & control)
  • Ovulation (drug effects, physiology)
  • Ovulation Induction (methods)
  • Pregnancy
  • Pregnancy Rate
  • Risk Factors
  • Triptorelin Pamoate (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: